tip

tip

TIP A COLLEAGUE

Key publications

Onset of action within depression

Escitalopram and suicidality in adult depression and anxiety

Pedersen et al., International Clinical Psychopharmacology 2005; 20: 139-143

Efficacy of escitalopram in patients with severe depression: a pooled analysis

Llorca, International Journal of Clinical Practice 2005; 59:268-275

Do equivalent doses of escitalopram and citalopram have similar efficacy: A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Lepola et al., International Clinical Psychopharmacology 2004, 19:149-155

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Lepola et al., International Clinical Psychopharmacology 2003; 18:211-217

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

Montgomery et al., Pharmacology & Toxicology 2001;88:282-286

Using meta-regression in performing indirectcomparisons: comparing escitalopram with venlafaxine XR

Eckert et al. Curr Med Res Opin 2006; 22(11): 2313-2321

Wade et al. Curr Med Res Opin 2006; 22 (11): 2101–2110

Wade et al. Curr Med Res Opin 2006; 22(11): 2101-2110

Escitalopram versus venlafaxine XR in the treatment of depression

Montgomery Int Clin Psychopharmacol 2006;21: 297-309

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer